SCHEMBL7423586

SCHEMBL7423586

COC(=O)c1cccc(NC(C)=O)c1OC(C)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.49
ALDH1A1 P00352 5/20 0.48
HSD17B10 Q99714 4/20 0.48
KMT2A Q03164 1/20 0.47
KDM4E B2RXH2 4/20 0.47
POLB P06746 2/20 0.47
ATM Q13315 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
MAPK1 P28482 3/20 0.46
ALOX15 P16050 2/20 0.46
CYP2C19 P33261 2/20 0.45
MAPT P10636 4/20 0.44
HPGD P15428 4/20 0.44
GAA P10253 2/20 0.43
TSHR P16473 2/20 0.43
CYP2C9 P11712 1/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SLC6A3 Q01959 1/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13255390 0.87 LMNA (0.51) LMNAALDH1A1HSD17B10KMT2AKDM4E
SCHEMBL17799560 0.86 HSD17B10 (0.61) LMNAALDH1A1HSD17B10KMT2AKDM4E
SCHEMBL3931825 0.82 TDP1 (0.51) LMNAALDH1A1HSD17B10KMT2AKDM4E
SCHEMBL19459538 0.81 PDK1 (0.46) LMNAALDH1A1HSD17B10KMT2AKDM4E
SCHEMBL29655205 0.80 KMT2A (0.71) LMNAALDH1A1HSD17B10KMT2AKDM4E
SCHEMBL1640485 0.80 KMT2A (0.71) LMNAALDH1A1HSD17B10KMT2AKDM4E
SCHEMBL31590548 0.79 LMNA (0.53) LMNAALDH1A1HSD17B10KMT2AKDM4E
SCHEMBL7426825 0.79 HSD17B10 (0.63) LMNAALDH1A1HSD17B10KMT2AKDM4E
SCHEMBL4026343 0.79 LMNA (0.53) LMNAALDH1A1HSD17B10KMT2AKDM4E
SCHEMBL18737813 0.79 SMN1; SMN2 (0.63) LMNAALDH1A1HSD17B10KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed